Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antioxidant therapeutic targets in COPD.

Irfan Rahman1, Iain Kilty

  • 1Department of Environmental Medicine, Division of Lung Biology and Disease, University of Rochester Medical Center, 601 Elmwood Ave., Box 850, Rochester, NY 14642, USA. irfan_rahman@urmc.rochester.edu

Current Drug Targets
|June 22, 2006
PubMed
Summary

Oxidative stress and inflammation drive chronic obstructive pulmonary disease (COPD). Antioxidants show promise for treating COPD by targeting these damaging processes and enhancing lung defenses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Clocks in Translational Roadmap for Circadian-Based Therapeutics in Lung Diseases.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

scRNA sequencing revealed HIV-associated inflammation-mediated lung epithelial dysregulation and fibroblast remodeling.

Frontiers in immunology·2026
Same author

SenSet defines cell-type specific senescence signatures in the aged human lung.

The EMBO journal·2026
Same author

Toxicity, Chemistry, and Public Health Relevance of Emerging Nicotine Analog Vapes, Pods, and Pouches.

Chemical research in toxicology·2026
Same author

PPAR-gamma regulates PFAS-mediated proinflammatory cytokines in lung epithelial cells.

Frontiers in pharmacology·2026
Same author

A comparative toxicological evaluation of nicotine and its analog 6-methyl nicotine in E-cigarette aerosol utilizing a 3D in vitro human respiratory model.

Toxicology·2026

Area of Science:

  • Pulmonary Medicine
  • Oxidative Stress Research
  • Pharmacology

Background:

  • Oxidative stress and chronic inflammation are key in chronic obstructive pulmonary disease (COPD) pathogenesis.
  • These processes negatively impact lung physiology, leading to impaired antiprotease function, mucus hypersecretion, and cellular damage.

Purpose of the Study:

  • To explore the therapeutic potential of antioxidants in managing COPD.
  • To review agents that target oxidative stress and inflammation in COPD treatment.

Main Methods:

  • Review of antioxidant and anti-inflammatory agents, including thiol molecules, polyphenols, and specific inhibitors.
  • Discussion of compounds like N-acetyl-L-cysteine, curcumin, resveratrol, and various spin traps and SOD mimetics.
  • Examination of approaches to enhance lung antioxidant capacity and relevant clinical trials.

Related Experiment Videos

Main Results:

  • Various antioxidant compounds demonstrate the ability to modulate inflammatory pathways (e.g., NF-kappaB activation) and gene expression.
  • Specific agents have shown efficacy in inhibiting smoke-induced inflammatory responses in vivo.
  • Multiple antioxidants may offer a synergistic therapeutic effect in COPD.

Conclusions:

  • Targeting oxidative stress with antioxidants is a promising therapeutic strategy for COPD.
  • Enhancing endogenous antioxidant levels or administering exogenous compounds could mitigate COPD progression.
  • Further clinical trials are needed to validate the efficacy of combined antioxidant therapies.